Home » Kinaxo To Analyze Protein PTMs for Boehringer Ingelheim

Kinaxo To Analyze Protein PTMs for Boehringer Ingelheim

Oct 13, 2008
NEW YORK (GenomeWeb News) – Kinaxo Biotechnologies said today that it will use its mass spectrometry platform to quantitatively analyze post-translational modifications of proteins for Boehringer Ingelheim.
 
Kinaxo, a spinout of the Max-Planck Institute of Biochemistry based in Martinsried, Germany, will use its Cellular Target Profiling technology to study the effects of different compounds on proteome-wide signal transduction pathways for the drugmaker.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Featured Webinar

Automated High-Throughput Protein Production of Human Proteins and Antibodies

Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.

What's Popular?

In Proteomics & Protein Research

  1. ShanghaiTech Team Develops New Proximity Labeling Approach

    Premium

  2. Newomics Using New Funding to Drive Commercialization of MEA Products

    Premium

  3. Signature Science Wins $2.3M Government Contract to Develop Forensic Tool

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.